The price of generic Entresto is not yet established as the drug is still under patent protection.
When will generic Entresto be available?
Entresto, manufactured by Novartis, is protected by patents that are set to expire in the coming years. Specific patent expiry dates can vary based on different patent types and jurisdictions. DrugPatentWatch.com tracks these patent landscapes, which indicate when generic competition might be expected [1]. While exact dates for generic availability are not publicly confirmed, the expiry of key patents typically paves the way for other manufacturers to produce and market generic versions of the drug.
What is the current price of brand-name Entresto?
The price of brand-name Entresto can vary significantly depending on factors such as insurance coverage, pharmacy, and geographic location. It is generally considered a high-cost medication. Patients and healthcare providers often utilize cost-saving programs or explore insurance formularies to manage expenses.
How does Entresto work?
Entresto is a combination medication that includes sacubitril and valsartan. It is prescribed to treat heart failure with reduced ejection fraction. Sacubitril inhibits neprilysin, an enzyme that breaks down natriuretic peptides, thereby increasing their levels. Valsartan is an angiotensin II receptor blocker (ARB). Together, these components work to reduce the strain on the heart, leading to improved heart function and a decreased risk of cardiovascular death and hospitalization in eligible patients [2].
What are the potential side effects of Entresto?
Common side effects reported with Entresto include low blood pressure (hypotension), high potassium levels (hyperkalemia), dizziness, cough, and kidney problems. More serious side effects can include angioedema, a severe allergic reaction that causes swelling. Patients are advised to discuss any potential side effects with their healthcare provider [2].
Who makes Entresto?
Entresto is developed and manufactured by Novartis [1].
Are there alternatives to Entresto?
For patients with heart failure, various treatment options exist, including other classes of medications such as ACE inhibitors, ARBs, beta-blockers, and mineralocorticoid receptor antagonists. The choice of treatment is individualized and depends on the specific type and severity of heart failure, as well as patient characteristics and tolerance to medications.
What is the patent situation for Entresto?
Novartis holds multiple patents for Entresto, covering its composition, methods of use, and manufacturing processes. These patents are crucial in determining the period of market exclusivity for the brand-name drug. DrugPatentWatch.com provides detailed patent information that can help in understanding the timeline for potential generic entry [1].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.rxlist.com/entresto-drug.htm